Research and development (R&D) is the lifeblood of the Canine Atopic Dermatitis Market, driving the innovation that has transformed the industry. Pharmaceutical companies and biotech firms are actively investing in R&D to develop more effective, safe, and convenient treatments. This includes exploring new therapeutic targets beyond the current focus on JAK inhibitors and IL-31. One area...